TDOC Teladoc Health RESULTS: Q2, Q2 REV $606.927M vs. EST $615.4M, Q2 basic EPS $-0.21, Q2 ADJ EBITDA $65.713M vs. EST $62M, Q2 Net Income $
TDOC Teladoc Health RESULTS: Q2, Q2 REV $606.927M vs. EST $615.4M, Q2 basic EPS $-0.21, Q2 ADJ EBITDA $65.713M vs. EST $62M, Q2 Net Income $-38.908M, Q2 EPS $-0.21, Teladoc Health Earnings Notes:, Outlook Q3 EPS $-0.3 to -0.2, Outlook FY ADJ EBITDA $271-303M vs. EST $279.8M, Outlook FY REV $2,362-2.447B vs. EST $2.508B, Outlook Q3 ADJ EBITDA $62-74M vs. EST $74.4M, Outlook FY EPS $-1 to -0.75, Outlook Q3 REV $569-609M vs. EST $629.3M
TDOC Teladoc Health RESULTS: Q2, Q2 REV $606.927M vs.
EST $615.4M, Q2 basic EPS $-0.21, Q2 ADJ EBITDA $65.713M vs.
EST $62M, Q2 Net Income $-38.908M, Q2 EPS $-0.21, Teladoc Health Earnings Notes:, Outlook Q3 EPS $-0.3 to -0.2, Outlook FY ADJ EBITDA $271-303M vs.
EST $279.8M, Outlook FY REV $2,362-2.447B vs.
EST $2.508B, Outlook Q3 ADJ EBITDA $62-74M vs.
EST $74.4M, Outlook FY EPS $-1 to -0.75, Outlook Q3 REV $569-609M vs.
EST $629.3M